Zeljko Vujaskovic Selected Research

AEOL 10150

10/2015	Dose Optimization Study of AEOL 10150 as a Mitigator of Radiation-Induced Lung Injury in CBA/J Mice.
7/2012	Temporal expression of hypoxia-regulated genes is associated with early changes in redox status in irradiated lung.
9/2011	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
11/2007	Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.
2/2007	Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zeljko Vujaskovic Research Topics

Disease

51	Neoplasms (Cancer) 01/2022 - 09/2002
30	Hyperthermia 01/2021 - 07/2004
25	Lung Injury 12/2017 - 06/2002
15	Hypoxia (Hypoxemia) 10/2015 - 07/2004
12	Breast Neoplasms (Breast Cancer) 07/2017 - 07/2004
11	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2010
10	Fibrosis (Cirrhosis) 11/2018 - 11/2003
8	Radiation Injuries (Radiation Sickness) 06/2020 - 06/2002
7	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2005
6	Erectile Dysfunction 01/2020 - 02/2011
6	Pneumonia (Pneumonitis) 06/2019 - 08/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2019 - 12/2004
6	Necrosis 09/2010 - 02/2005
5	Inflammation (Inflammations) 01/2019 - 11/2007
5	Sarcoma (Soft Tissue Sarcoma) 04/2018 - 10/2006
5	Carcinoma (Carcinomatosis) 06/2007 - 01/2006
4	Neoplasm Metastasis (Metastasis) 12/2016 - 02/2005
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 03/2012
3	Wounds and Injuries (Trauma) 01/2017 - 05/2012
3	Carcinogenesis 12/2015 - 06/2007
2	Chordoma 12/2021 - 01/2021
2	Pain (Aches) 01/2021 - 05/2014
2	Dehydration (Water Stress) 01/2021 - 01/2021
2	Radiation Pneumonitis 06/2019 - 04/2011
2	Pulmonary Edema 10/2015 - 11/2003
2	Body Weight (Weight, Body) 04/2010 - 03/2008
2	Rectal Neoplasms (Rectal Cancer) 06/2009 - 05/2007
1	Vascular System Injuries 01/2022
1	Hemorrhage 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2004
9	CytokinesIBA 01/2008 - 06/2002
8	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 10/2002
6	Pharmaceutical PreparationsIBA 01/2020 - 10/2005
6	Superoxide DismutaseIBA 03/2018 - 11/2003
6	Carbonic Anhydrase IXIBA 01/2018 - 12/2004
6	AntioxidantsIBA 07/2012 - 02/2007
5	Protons (Proton)IBA 12/2021 - 04/2004
5	AEOL 10150IBA 10/2015 - 02/2007
5	PorphyrinsIBA 05/2012 - 10/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2010 - 07/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2010 - 09/2005
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015 - 06/2002
4	Oxygen (Dioxygen)IBA 04/2010 - 07/2004
3	Caveolin 1IBA 01/2022 - 12/2016
3	LipidsIBA 06/2020 - 02/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2018 - 01/2010
3	liposomal doxorubicin (Doxil)FDA Link 08/2014 - 02/2006
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2014 - 03/2012
3	CollagenIBA 08/2013 - 11/2003
3	Indicators and Reagents (Reagents)IBA 09/2011 - 11/2003
3	pimonidazoleIBA 09/2010 - 10/2009
2	Biological ProductsIBA 12/2021 - 12/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	AntipyreticsIBA 01/2021 - 01/2021
2	Hormones (Hormone)IBA 01/2020 - 10/2019
2	GenisteinIBA 10/2019 - 12/2017
2	Ifosfamide FDA LinkGeneric 04/2018 - 06/2010
2	Etoposide (VP 16)FDA LinkGeneric 04/2018 - 06/2010
2	Mn(III) ortho- tetrakis(N- hexylpyridinium- 2- yl)porphyrinIBA 03/2018 - 03/2008
2	Phosphotransferases (Kinase)IBA 12/2016 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 10/2009
2	salicylhydroxamic acid (SHAM)IBA 07/2012 - 10/2002
2	ManganeseIBA 04/2010 - 10/2005
2	NitrogenIBA 04/2010 - 03/2008
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2009 - 12/2004
2	Fluorouracil (Carac)FDA LinkGeneric 06/2009 - 05/2007
2	Bevacizumab (Avastin)FDA Link 06/2009 - 05/2007
2	Erythropoietin FDA Link 06/2007 - 02/2006
2	Glucose (Dextrose)FDA LinkGeneric 10/2005 - 06/2005
2	Amifostine (Ethyol)FDA LinkGeneric 10/2002 - 06/2002
1	AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Death Domain ReceptorsIBA 01/2021
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	Brachyury protein (Brachyury)IBA 01/2021
1	OX40 ReceptorsIBA 04/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	VimentinIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020

Therapy/Procedure

45	Radiotherapy 12/2021 - 09/2002
21	Therapeutics 12/2021 - 04/2005
12	Drug Therapy (Chemotherapy) 11/2018 - 02/2006
6	Neoadjuvant Therapy 04/2018 - 02/2006
5	Proton Therapy 12/2021 - 07/2016
3	Immunotherapy 04/2020 - 11/2018
2	Pain Management 01/2021 - 10/2009
2	Induced Hyperthermia (Thermotherapy) 01/2020 - 08/2014
2	Chemoradiotherapy 06/2019 - 06/2009
2	Aftercare (After-Treatment) 01/2017 - 09/2010
2	Catheters 05/2014 - 11/2009
2	Cryosurgery 09/2010 - 08/2010
2	Mastectomy (Mammectomy) 01/2010 - 07/2004
1	Cyclotrons 12/2021
1	Precision Medicine 01/2021
1	Intraperitoneal Injections 04/2020